Table 1.
Gene ID/accession | Gene name | Resistance type | PA30 genotype | PA49 genotype | Affected antibioticsa |
---|---|---|---|---|---|
gi|32470063 | aac(6’)-Ib | AAC(6’) | – | Present | Aminoglycosides (GM, AN) |
gi|378773997 | aadB | ANT(2'’) | – | Present | Aminoglycosides (GM, AN) |
gi|489251134 | blaVIM-2 | VIM | – | Present | Beta-lactams (AZ, CAZ, PT) |
gi|88853419 | aadA10 | ANT(3'’) | – | Present | Aminoglycosides |
gi|489211498 | – | AmpC | – | Present | Beta-lactams (AZ, CAZ, PT) |
gi|489217979 | – | Metallo-beta-lactamase | – | Present | Beta-lactams (AZ, CAZ, PT) |
gi|407937916 | – | Metallo-beta-lactamase | Present | – | Beta-lactams (AZ, CAZ, PT) |
PA3168 | gyrA | Target modification | wt | T83I | Fluoroquinolones (CIP) |
PA4964 | parC | Target modification | wt | S87L | Fluoroquinolones (CIP) |
PA0958 | oprD | Decreased permeability | Multiple SNPs | Multiple SNPs, frameshift | Carbapenems (IPM) |
insertion CC at position 279 |
Abbreviations indicate specific antibiotics. AN, amikacin; PT, Piperacillin + Tazobactam.
AZ, azlocillin; CAZ, ceftazidime; CIP, ciprofloxacin; GM, gentamicin; IPM, imipenem.